Dose-Escalation Study of SCD-101 in Sickle Cell Disease
Phase 1
Active, not recruiting
- Conditions
- Sickle Cell DiseaseSickle-Beta Zero Thalassemia
- Interventions
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Invenux, LLC
- Target Recruit Count
- 60
- Registration Number
- NCT02380079
- Locations
- 🇺🇸
King's County Hospital, Brooklyn, New York, United States
© Copyright 2025. All Rights Reserved by MedPath